Showing results (291-300 of 548) with videos related to
Sort By:
Pageof 55
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 1, 2013
Estimation of GFR in South Asians: a study from the general population in PakistanSaleem Jessani, Andrew S Levey, Rasool Bux, et al.Journal of the American Society of Nephrology : JASN|June 13, 2025
Obesity, Underweight, and Accuracy of eGFR Using Cystatin C and Creatinine in a Northern European PopulationWilliam A Russel, Edouard L Fu, Alessandro Bosi, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 8, 2005
Factors associated with lipoprotein(a) in chronic kidney diseaseKatrin Uhlig, Shin-Ru Wang, Gerald J Beck, et al.The Lancet. Oncology|September 2, 2006
Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort studyWilliam C Huang, Andrew S Levey, Angel M Serio, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 27, 2013
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimatesMorgan E Grams, Stephen P Juraschek, Elizabeth Selvin, et al.Journal of the American Society of Nephrology : JASN|July 23, 2003
Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO studyMark Unruh, Guofen Yan, Milena Radeva, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug AdministrationAndrew S Levey, Lesley A Inker, Kunihiro Matsushita, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 3, 2014
GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trialsLesley A Inker, Hiddo J Lambers Heerspink, Hasi Mondal, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 8, 2016
Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) TrialTaimur Dad, Hocine Tighiouart, Alin Joseph, et al.Journal of the American College of Cardiology|September 1, 1988
Adult cardiology and the expanding supply of physiciansJ J Leonard, H J Swan, K Dracup, et al.Pageof 55